Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia Plans Stronger Panel To Oversee Approved Drugs

This article was originally published in PharmAsia News

Executive Summary

The Australian government is considering replacing its Adverse Drug Reactions Advisory Committee in charge of drug safety with a Medicines Safety Committee. The intent is to overhaul the nation's system for ensuring drug safety. The new agency is expected to be given the authority for rigorous surveillance of prescription drugs that have passed the country's approval process. Other changes planned include drug audits and appointment of a drug monitor for checking the safety of specific drugs. The Medicines Safety Committee also would have greater oversight authority of risk-management plans of makers of approved drug products. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067575

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel